William D. Snider
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
William D. Snider has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
D. E. Wright
Center for the Study of Nervous System Injury, Department of Neurology, Washington University School of Medicine, 660 S. Euclid Ave., Box 8111, St. Louis, MO 63110, USA US
1 shared publication- Derek C. Molliver
Department of Biomedical Sciences, College of Osteopathic Medicine, University of New England, Biddeford, ME 04005, USA
1 shared publication J.H. Miner
Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63110
1 shared publicationJ.R. Sanes
Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63110
1 shared publicationS.I. Lentz
Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA
1 shared publicationShigeru Ozaki
Center for the Study of Nervous System Injury, Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110
1 shared publication
Latest Publications
- 1 May 1998
- Published by Springer Nature in Nature Neuroscience
- Vol. 1 (1) , 5-6
How do you feel? Neurotrophins and mechanotransduction
- 1 May 1998
- Published by Springer Nature in Nature Neuroscience
- Vol. 1 (1) , 5-6
How do you feel? Neurotrophins and mechanotransduction
- 19 May 1997
- Published by Wiley in Journal of Comparative Neurology
- Vol. 381 (4) , 428-438
Nerve growth factor receptor trkA is down-regulated during postnatal development by a subset of dorsal root ganglion neurons
Nerve growth factor (NGF), signaling through its receptor tyrosine kinase, TrkA, is required for the survival of all small and many intermediate-sized murine dorsal root ganglion (DRG) neurons during development, accounting for 80% of the total DRG population. Surprisingly, NGF/TrkA-dependent neurons include a large population that does not express TrkA in adult mice (Silos-Santiago et al., 1995). This finding suggests two hypotheses: Neurons lacking TrkA in the adult may express TrkA during development, or they may be maintained through a paracrine mechanism by TrkA-expressing neurons. To determine whether TrkA is expressed transiently by DRG neurons that lack the receptor in adulthood, we examined the distribution of TrkA protein during development. We show here that TrkA expression is strikingly developmentally regulated. Eighty percent of DRG neurons expressed TrkA during embryogenesis and early postnatal life, whereas only 43% expressed TrkA at postnatal day (P) 21. Because the period of TrkA down-regulation corresponds with a critical period during which nociceptive phenotype can be altered by NGF (see Lewin and Mendell [1993] Trends Neurosci. 16:353-359), we examined whether NGF modulates the down-regulation of TrkA. Surprisingly, neither NGF deprivation nor augmentation altered the extent of TrkA down-regulation. Our results demonstrate a novel form of regulation of neurotrophin receptor expression that occurs late in development. All DRG neurons that require NGF for survival express TrkA during embryogenesis, and many continue to express TrkA during a postnatal period when neuronal phenotype is regulated by NGF. The subsequent down-regulation of TrkA is likely to be importantly related to functional distinctions among nociceptive neurons in maturity. J. Comp. Neurol. 381:428-438, 1997.
- 19 May 1997
- Published by Wiley in Journal of Comparative Neurology
- Vol. 381 (4) , 428-438
Nerve growth factor receptor trkA is down-regulated during postnatal development by a subset of dorsal root ganglion neurons
Nerve growth factor (NGF), signaling through its receptor tyrosine kinase, TrkA, is required for the survival of all small and many intermediate-sized murine dorsal root ganglion (DRG) neurons during development, accounting for 80% of the total DRG population. Surprisingly, NGF/TrkA-dependent neurons include a large population that does not express TrkA in adult mice (Silos-Santiago et al., 1995). This finding suggests two hypotheses: Neurons lacking TrkA in the adult may express TrkA during development, or they may be maintained through a paracrine mechanism by TrkA-expressing neurons. To determine whether TrkA is expressed transiently by DRG neurons that lack the receptor in adulthood, we examined the distribution of TrkA protein during development. We show here that TrkA expression is strikingly developmentally regulated. Eighty percent of DRG neurons expressed TrkA during embryogenesis and early postnatal life, whereas only 43% expressed TrkA at postnatal day (P) 21. Because the period of TrkA down-regulation corresponds with a critical period during which nociceptive phenotype can be altered by NGF (see Lewin and Mendell [1993] Trends Neurosci. 16:353-359), we examined whether NGF modulates the down-regulation of TrkA. Surprisingly, neither NGF deprivation nor augmentation altered the extent of TrkA down-regulation. Our results demonstrate a novel form of regulation of neurotrophin receptor expression that occurs late in development. All DRG neurons that require NGF for survival express TrkA during embryogenesis, and many continue to express TrkA during a postnatal period when neuronal phenotype is regulated by NGF. The subsequent down-regulation of TrkA is likely to be importantly related to functional distinctions among nociceptive neurons in maturity. J. Comp. Neurol. 381:428-438, 1997.
- 7 April 1997
- Published by Wiley in Journal of Comparative Neurology
- Vol. 380 (2) , 215-229
Initial trajectories of sensory axons toward laminar targets in the developing mouse spinal cord
- 7 April 1997
- Published by Wiley in Journal of Comparative Neurology
- Vol. 380 (2) , 215-229
Initial trajectories of sensory axons toward laminar targets in the developing mouse spinal cord
- 24 February 1997
- Published by Wiley in Journal of Comparative Neurology
- Vol. 378 (4) , 547-561
Distribution of the ten known laminin chains in the pathways and targets of developing sensory axons
Laminins are heterotrimers of α, β and γ chains. At present, five α, three β, and two γ chains have been described. The best characterized laminin (laminin 1 = α1, β1, γ1) promotes neurite outgrowth from virtually all classes of developing neurons, implying that laminins may serve as axon guidance molecules in vivo. Moreover, different laminin trimers exert distinct effects on subsets of laminin-1-responsive cells, suggesting that isoform diversity may underlie some axonal choices in vivo. As a first step toward evaluating these hypotheses, we have documented the expression patterns of all 10 known laminin chains in the peripheral nervous system and spinal cord of the murine embryo. The α2, α4, β1, and γ1 chains are expressed in peripheral axonal pathways by embryonic day (E) 11.5, when sensory and motor axonal outgrowth is underway. Thus, laminins (but not laminin 1) may promote peripheral axonal outgrowth. By E 13.5, laminin chains are differentially expressed in the limb-bud, with prominent expression of α2 and α4 in muscle and of α3 and α5 in skin. This pattern raises the possibility that laminin isoform diversity contributes to the ability of cutaneous and muscle sensory axons to distinguish their targets. Later in development, some chains (e.g., α2, α4, and β1) are downregulated in peripheral nerve while others (e.g., γ1), continue to be expressed by Schwann cells into adulthood. In contrast to peripheral nerves and ganglia, laminin chains are expressed at low levels, if at all, in the developing spinal cord gray matter. J. Comp. Neurol. 378:547–561, 1997.
- 24 February 1997
- Published by Wiley in Journal of Comparative Neurology
- Vol. 378 (4) , 547-561
Distribution of the ten known laminin chains in the pathways and targets of developing sensory axons
Laminins are heterotrimers of α, β and γ chains. At present, five α, three β, and two γ chains have been described. The best characterized laminin (laminin 1 = α1, β1, γ1) promotes neurite outgrowth from virtually all classes of developing neurons, implying that laminins may serve as axon guidance molecules in vivo. Moreover, different laminin trimers exert distinct effects on subsets of laminin-1-responsive cells, suggesting that isoform diversity may underlie some axonal choices in vivo. As a first step toward evaluating these hypotheses, we have documented the expression patterns of all 10 known laminin chains in the peripheral nervous system and spinal cord of the murine embryo. The α2, α4, β1, and γ1 chains are expressed in peripheral axonal pathways by embryonic day (E) 11.5, when sensory and motor axonal outgrowth is underway. Thus, laminins (but not laminin 1) may promote peripheral axonal outgrowth. By E 13.5, laminin chains are differentially expressed in the limb-bud, with prominent expression of α2 and α4 in muscle and of α3 and α5 in skin. This pattern raises the possibility that laminin isoform diversity contributes to the ability of cutaneous and muscle sensory axons to distinguish their targets. Later in development, some chains (e.g., α2, α4, and β1) are downregulated in peripheral nerve while others (e.g., γ1), continue to be expressed by Schwann cells into adulthood. In contrast to peripheral nerves and ganglia, laminin chains are expressed at low levels, if at all, in the developing spinal cord gray matter. J. Comp. Neurol. 378:547–561, 1997.
- 29 October 1996
- Published by Springer Nature in Cell and tissue research
- Vol. 286 (2) , 209-217
Focal expression of glial cell line-derived neurotrophic factor in developing mouse limb bud
Glial cell line-derived neurotrophic factor (GDNF) is known to support the survival of motoneurons in vitro and in vivo, as well as subpopulations of sensory neurons in vitro. To clarify the mechanisms by which GDNF supports these neurons, we examined the patterns of GDNF mRNA expression in relation to motor and sensory axons during early stages of mouse development. Between embryonic days (E) 10 and 12, a time when motor and sensory axons are entering the periphery, GDNF mRNA is expressed at high levels in a restricted region in proximal limb buds where axons converge and enter the limb. At later ages (E14–16), GDNF mRNA was detected in non-neuronal cells along peripheral nerve, in dermis, and in some muscles. To characterize cells that express GDNF in the proximal limb, GDNF expression in the forelimb was compared to expression patterns of two markers of muscle, Pax 3 and myogenin, as well as with the pan neurotrophin receptor (p75) which is expressed by Schwann cell precursors. We show that expression of GDNF in the proximal limb bud at E11–12 does not correlate with markers of muscle or Schwann cell precursors, which supports the idea that GDNF is expressed by mesenchymal cells in this region. Our results suggest that GDNF expression in proximal limb buds may function as a transient survival factor, particularly for motor neurons, before they reach their final targets. GDNF expression in muscle and dermis at later stages suggests that GDNF may have additional functions as motor and sensory neurons mature.
- 29 October 1996
- Published by Springer Nature in Cell and tissue research
- Vol. 286 (2) , 209-217
Focal expression of glial cell line-derived neurotrophic factor in developing mouse limb bud
Glial cell line-derived neurotrophic factor (GDNF) is known to support the survival of motoneurons in vitro and in vivo, as well as subpopulations of sensory neurons in vitro. To clarify the mechanisms by which GDNF supports these neurons, we examined the patterns of GDNF mRNA expression in relation to motor and sensory axons during early stages of mouse development. Between embryonic days (E) 10 and 12, a time when motor and sensory axons are entering the periphery, GDNF mRNA is expressed at high levels in a restricted region in proximal limb buds where axons converge and enter the limb. At later ages (E14–16), GDNF mRNA was detected in non-neuronal cells along peripheral nerve, in dermis, and in some muscles. To characterize cells that express GDNF in the proximal limb, GDNF expression in the forelimb was compared to expression patterns of two markers of muscle, Pax 3 and myogenin, as well as with the pan neurotrophin receptor (p75) which is expressed by Schwann cell precursors. We show that expression of GDNF in the proximal limb bud at E11–12 does not correlate with markers of muscle or Schwann cell precursors, which supports the idea that GDNF is expressed by mesenchymal cells in this region. Our results suggest that GDNF expression in proximal limb buds may function as a transient survival factor, particularly for motor neurons, before they reach their final targets. GDNF expression in muscle and dermis at later stages suggests that GDNF may have additional functions as motor and sensory neurons mature.